SUMMARY Clinical and biochemical findings in skeletal muscle in 11 patients with chronic fatigue myalgia syndromes of unknown aetiology are reported. All patients had severe asthenia for from one to 10 years with greatly limited exercise capacity and protracted exhaustion after minor exercise. Diffuse myalgia was prominent and was exacerbated for hours to days after exercise. Assay of skeletal muscle carnitine, phosphorylase, all glycolytic enzymes and the mitochondrial marker enzymes monoamine oxidase, isocitrate dehydrogenase and cytochrome oxidase were normal. These findings lend no support to the presence of a major defect in muscle intermediary energy pathways in this syndrome.
Severe asthenia and myalgia of obscure aetiology and protracted course is a common problem and has been designated as post viral fatigue syndrome,' epidemic myalgic encephalomyelitis,2 epidemic neuromyasthenia3 and Royal Free disease. Sporadic cases are more common than epidemic cases' and there is considerable dispute as to whether this disorder has an organic or a psychogenic basis.' 4 s Defects in intermediary muscle metabolism are well recognised as causes of both fatigability and myalgia. Mitochondrial deficiencies may be associated with prominent fatigability6-8 and exercise induced myalgia characterises disorders of glycogenolysis and glycolysis.9 12 Although the clinical features of the chronic fatigue and myalgia syndrome differ from those of well established deficiences in intermediary energy metabolism, the possibility merits consideration that a subtle metabolic derangement may have a pathogenic role in this syndrome. Recent MRI studies have provided some support for this postulate.'3 The possibility of a deficiency in intermediary energy pathways was explored in this study by assay of muscle glycolytic and mitochondrial marker enzymes, phosphorylase and carnitine in a group of 11 patients. Figures show umol substrate used/min/g muscle wet weight.
group Table 3 Mitochondrial marker enzyme activity and carnitine levels in patient and control groups (n = 14)
*p < 0-05 when compared with patient group. All other differences not significant (unpaired Student's t test).
the elderly orthopaedic control group where histology was not examined.
Discussion
The patients presented in this report all had severe protracted asthenia with myalgia, both symptoms being exacerbated by exercise. The clinical features resembled patients reported as having postviral fatigue syndrome with the exception that a viral infection was never proven and only suggested on historical grounds in half the cases. The link of this syndrome to antecedent viraemia is not always proven and we prefer the designation "idiopathic chronic asthenia and myalgia syndrome" to postviral fatigue syndrome.
Patients with this disorder are generally resistant of cure both with physical and psychological treatments and are often referred to a neurologist with an interest in myology as a last resort with the question as to whether a metabolic defect in skeletal muscle is possible. The findings in this study exclude a defect in phosphorylase and all glycolytic enzymes. A major global reduction in mitochondrial activity is excluded by the normality of enzymes representing outer membrane, inner membrane and matrix activity in this study, although a very selective deficiency of a mitochondrial enzyme not measured has not been excluded. The explanation for the lower glycolytic activity found in the elderly control group is not clear. It is possible that this may reflect type 2b fibre atrophy related to relative inactivity in that group and this possibility will be explored further.
The findings in this study suggest that routine muscle biopsy in the hope of pinpointing a specific metabolic abnormality is of little value in idiopathic fatigue and myalgia syndrome (post viral fatigue) and muscle biopsy should only be considered in this setting as a research procedure when novel studies are being undertaken. 
